Effect of green tea on glucose control and insulin sensitivity : a meta-analysis of 17 randomized controlled trials 1 – 3
暂无分享,去创建一个
Ka Chen | Jun-dong Zhu | M. Mi | Kai Liu | Bin Wang | Rui Zhou | Lin Shi | Man‐tian Mi | Jun‐dong Zhu
[1] M. Hosseinzadeh‐Attar,et al. Effect of green tea extract on bone turnover markers in type 2 diabetic patients; A double- blind, placebo-controlled clinical trial study , 2015 .
[2] P. Bogdański,et al. Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients. , 2012, Nutrition research.
[3] P. Bogdański,et al. Effects of Green Tea Supplementation on Elements, Total Antioxidants, Lipids, and Glucose Values in the Serum of Obese Patients , 2012, Biological Trace Element Research.
[4] M. Pike,et al. Effect of 2-Month Controlled Green Tea Intervention on Lipoprotein Cholesterol, Glucose, and Hormone Levels in Healthy Postmenopausal Women , 2012, Cancer Prevention Research.
[5] S. Kuriyama,et al. Randomized controlled trial for an effect of catechin-enriched green tea consumption on adiponectin and cardiovascular disease risk factors , 2011, Food & nutrition research.
[6] Xue-mei Wang,et al. A randomized double-blind placebo-controlled study of Pu’er tea (普洱茶) extract on the regulation of metabolic syndrome , 2011, Chinese journal of integrative medicine.
[7] M. Ezzati,et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants , 2011, The Lancet.
[8] T. Dadd,et al. Health effects of green tea catechins in overweight and obese men: a randomised controlled cross-over trial , 2011, British Journal of Nutrition.
[9] T. Tsai,et al. Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial. , 2011, Alternative medicine review : a journal of clinical therapeutic.
[10] S. Hansen,et al. Randomized and double-blinded pilot clinical study of the safety and anti-diabetic efficacy of the Rauvolfia-Citrus tea, as used in Nigerian traditional medicine. , 2011, Journal of ethnopharmacology.
[11] D. Baer,et al. Oolong tea does not improve glucose metabolism in non-diabetic adults , 2011, European Journal of Clinical Nutrition.
[12] J. Bea,et al. Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors. , 2010, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.
[13] R. Kuttan,et al. Beneficial effects of green tea: A literature review , 2010, Chinese medicine.
[14] C. Ostenson,et al. Antidiabetic Effect of Gynostemma pentaphyllum Tea in Randomly Assigned Type 2 Diabetic Patients* , 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[15] Mingyuan Wu,et al. Green Tea Supplementation Affects Body Weight, Lipids, and Lipid Peroxidation in Obese Subjects with Metabolic Syndrome , 2010, Journal of the American College of Nutrition.
[16] D. Mozaffarian,et al. Lifestyle risk factors and new-onset diabetes mellitus in older adults: the cardiovascular health study. , 2009, Archives of internal medicine.
[17] Davide Grassi,et al. Black tea consumption dose-dependently improves flow-mediated dilation in healthy males , 2009, Journal of hypertension.
[18] Yun Hu,et al. Tea Consumption and Risk of Type 2 Diabetes: A Meta-Analysis of Cohort Studies , 2009, Journal of General Internal Medicine.
[19] T. Hase,et al. A Catechin‐rich Beverage Improves Obesity and Blood Glucose Control in Patients With Type 2 Diabetes , 2009, Obesity.
[20] J. Lane,et al. Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial , 2008, British Journal of Nutrition.
[21] H. Iso,et al. Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities , 2008, European Journal of Clinical Nutrition.
[22] K. Sabitha,et al. Effect of green tea extract on advanced glycation and cross-linking of tail tendon collagen in streptozotocin induced diabetic rats. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[23] Cynthia Balion,et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. , 2007, Diabetes research and clinical practice.
[24] W. B. Brooks,et al. The effect of an extract of green and black tea on glucose control in adults with type 2 diabetes mellitus: double-blind randomized study. , 2007, Metabolism: clinical and experimental.
[25] R. Ross,et al. Can EGCG Reduce Abdominal Fat in Obese Subjects? , 2007, Journal of the American College of Nutrition.
[26] H. Mukhtar,et al. Tea polyphenols for health promotion. , 2007, Life sciences.
[27] T. Hase,et al. A Green Tea Extract High in Catechins Reduces Body Fat and Cardiovascular Risks in Humans , 2007, Obesity.
[28] P. Srinivasan,et al. Green tea attenuates diabetes induced Maillard-type fluorescence and collagen cross-linking in the heart of streptozotocin diabetic rats. , 2007, Pharmacological research.
[29] Ying Wang,et al. Epigallocatechin gallate supplementation alleviates diabetes in rodents. , 2006, The Journal of nutrition.
[30] T. Oya,et al. Therapeutic Potential of (-)-Epigallocatechin 3-O-Gallate on Renal Damage in Diabetic Nephropathy Model Rats , 2006, Journal of Pharmacology and Experimental Therapeutics.
[31] K. Sabitha,et al. Green tea impedes dyslipidemia, lipid peroxidation, protein glycation and ameliorates Ca2+ -ATPase and Na+/K+ -ATPase activity in the heart of streptozotocin-diabetic rats. , 2006, Chemico-biological interactions.
[32] K. Adeli,et al. Green tea leaf extract improves lipid and glucose homeostasis in a fructose-fed insulin-resistant hamster model. , 2006, Journal of ethnopharmacology.
[33] K. Choi,et al. Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. , 2006, Diabetes research and clinical practice.
[34] M. Westerterp-Plantenga,et al. Metabolic effects of green tea and of phases of weight loss , 2006, Physiology & Behavior.
[35] W. Yeung,et al. Effects of Chinese Green Tea on Weight, and Hormonal and Biochemical Profiles in Obese Patients With Polycystic Ovary Syndrome—A Randomized Placebo-Controlled Trial , 2006, The Journal of the Society for Gynecologic Investigation: JSGI.
[36] H. Iso,et al. Randomized controlled trial for an effect of green tea consumption on insulin resistance and inflammation markers. , 2005, Journal of nutritional science and vitaminology.
[37] S. D. Quine,et al. Effects of (-)-epicatechin, a flavonoid on lipid peroxidation and antioxidants in streptozotocin-induced diabetic liver, kidney and heart. , 2005, Pharmacological reports : PR.
[38] Ying Wang,et al. TEAVIGOTM (Epigallocatechin Gallate) Supplementation Prevents Obesity in Rodents by Reducing Adipose Tissue Mass , 2005, Annals of Nutrition and Metabolism.
[39] Mark A. Smith,et al. Paradoxical effects of green tea (Camellia sinensis) and antioxidant vitamins in diabetic rats: improved retinopathy and renal mitochondrial defects but deterioration of collagen matrix glycoxidation and cross-linking. , 2005, Diabetes.
[40] K. Shimada,et al. Oolong tea increases plasma adiponectin levels and low-density lipoprotein particle size in patients with coronary artery disease. , 2004, Diabetes research and clinical practice.
[41] Liang-Yi Wu,et al. Effect of green tea supplementation on insulin sensitivity in Sprague-Dawley rats. , 2004, Journal of agricultural and food chemistry.
[42] Liang-Yi Wu,et al. Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model , 2004, European journal of nutrition.
[43] H. Ashida,et al. Anti‐obesity actions of green tea: Possible involvements in modulation of the glucose uptake system and suppression of the adipogenesis‐related transcription factors , 2004, BioFactors.
[44] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[45] Myung-Kwan Han,et al. Epigallocatechin gallate prevents autoimmune diabetes induced by multiple low doses of streptozotocin in mice , 2003, Archives of pharmacal research.
[46] B. Clevidence,et al. Antihyperglycemic effect of oolong tea in type 2 diabetes. , 2003, Diabetes care.
[47] D. Min,et al. Protective Effects of Epicatechin Against the Toxic Effects of Streptozotocin on Rat Pancreatic Islets: In Vivo and in Vitro , 2003, Pancreas.
[48] D. Granner,et al. Epigallocatechin Gallate, a Constituent of Green Tea, Represses Hepatic Glucose Production* , 2002, The Journal of Biological Chemistry.
[49] Anson,et al. DIET , LIFESTYLE , AND THE RISK OF TYPE 2 DIABETES MELLITUS IN WOMEN , 2001 .
[50] E. Ryan,et al. Herbal tea in the treatment of diabetes mellitus. , 2000, Clinical and investigative medicine. Medecine clinique et experimentale.
[51] D. Cook,et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? , 1998, The Lancet.
[52] J. Cutler,et al. Variance imputation for overviews of clinical trials with continuous response. , 1992, Journal of clinical epidemiology.